NUVL - Financial Reports List - Nuvalent, Inc. - IntrinsicAlpha

Nuvalent, Inc. NUVL

Healthcare - Biotechnology - NASDAQ - US

$ 74.0259

-2.93 %

$ 5.32 B

Market Cap

-16.67

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	-90.15%	-80.29%
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-95.24%	-85.84%
Annual Report	FY	10-K	2024-12-31	0.00%	-106.59%	-87.55%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-150.69%	-96.82%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-96.51%	-91.27%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-120.49%	-74.07%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-93.68%	-58.49%
Annual Report	FY	10-K	2023-12-31	0.00%	-72.09%	-73.61%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-76.67%	-90.22%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-59.84%	-81.83%

1